JPH05508843A - アルツハイマー病の処置のための組成物及びそれを調製するための方法 - Google Patents

アルツハイマー病の処置のための組成物及びそれを調製するための方法

Info

Publication number
JPH05508843A
JPH05508843A JP91512036A JP51203691A JPH05508843A JP H05508843 A JPH05508843 A JP H05508843A JP 91512036 A JP91512036 A JP 91512036A JP 51203691 A JP51203691 A JP 51203691A JP H05508843 A JPH05508843 A JP H05508843A
Authority
JP
Japan
Prior art keywords
disease
alzheimer
physostigmine
aminopyridine
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP91512036A
Other languages
English (en)
Japanese (ja)
Inventor
ビジ，シベステル
シルベレキ，イュノェ
リテラーティ，ナギ　ペーテル
Original Assignee
ビオレックス　クタト―フェイレストェー　コルラートルト　フェレロェセーギュー　タールシャシャーグ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ビオレックス　クタト―フェイレストェー　コルラートルト　フェレロェセーギュー　タールシャシャーグ filed Critical ビオレックス　クタト―フェイレストェー　コルラートルト　フェレロェセーギュー　タールシャシャーグ
Publication of JPH05508843A publication Critical patent/JPH05508843A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP91512036A 1990-07-12 1991-07-11 アルツハイマー病の処置のための組成物及びそれを調製するための方法 Pending JPH05508843A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU4191/90 1990-07-12
HU904191A HU207444B (en) 1990-07-12 1990-07-12 Method for producing therapeutical preparation suitable for treating alzheimer-disease

Publications (1)

Publication Number Publication Date
JPH05508843A true JPH05508843A (ja) 1993-12-09

Family

ID=10967276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP91512036A Pending JPH05508843A (ja) 1990-07-12 1991-07-11 アルツハイマー病の処置のための組成物及びそれを調製するための方法

Country Status (8)

Country Link
EP (1) EP0607125A1 (de)
JP (1) JPH05508843A (de)
AU (1) AU645826B2 (de)
CZ (1) CZ280474B6 (de)
HU (1) HU207444B (de)
IE (1) IE912431A1 (de)
WO (1) WO1992000737A1 (de)
ZA (1) ZA915462B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0730463B1 (de) * 1993-11-26 2000-02-02 Karla Lehmann Verwendung von lithiumverbindungen zur behandlung und prophylaxe des morbus alzheimer
IL138192A0 (en) 1998-03-11 2001-11-25 Smithkline Beecham Plc Controlled release oral dosage forms

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278679A (en) * 1980-05-01 1981-07-14 Chromalloy American Corporation Combination of two or more drugs in a single dosage form wherein one of the drugs is a physostigmine compound
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment

Also Published As

Publication number Publication date
HU904191D0 (en) 1990-12-28
WO1992000737A1 (en) 1992-01-23
IE912431A1 (en) 1992-01-15
AU645826B2 (en) 1994-01-27
AU8205391A (en) 1992-02-04
HUT58519A (en) 1992-03-30
CZ280474B6 (cs) 1996-01-17
EP0607125A1 (de) 1994-07-27
HU207444B (en) 1993-04-28
ZA915462B (en) 1992-04-29
CS216591A3 (en) 1992-04-15

Similar Documents

Publication Publication Date Title
Sival et al. Sodium valproate in the treatment of aggressive behavior in patients with dementia—a randomized placebo controlled clinical trial
SWEET et al. Mental symptoms in Parkinson's disease during chronic treatment with levodopa
Mimori et al. Thiamine therapy in Alzheimer's disease
US10463655B2 (en) Method of treatment with tradipitant
HUE035105T2 (en) A composition comprising nicotine and opipramole and its use
MX2012001814A (es) Uso de 4-aminopiridina para mejorar la discapacidad neuro - cognoscitiva y/o neuro - psiquiatrica en pacientes con condiciones desmielizantes y otras condiciones del sistema nervioso.
CN116712423A (zh) 治疗特定患者群体的神经变性病症的方法
Moretti Available and future treatments for atypical parkinsonism. A systematic review
WO2001078704A2 (en) Gaba substrate and the use thereof for treating cognitive and emotional disorders
US8557310B2 (en) Composition to retard the onset of symptoms of alzheimer's disease
Saeedi et al. Challenges and approaches of drugs such as memantine, donepezil, rivastigmine, and aducanumab in the treatment, control and management of Alzheimer's disease
EP1784177B1 (de) Formulierung für l-tryptophan mit carbidopa/ benserazid
CA2518886A1 (en) Method for treating mild cognitive impairment and for preventing or delaying alzheimer's disease
BRINKMAN et al. A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease)
JPH10182471A (ja) 医薬組成物及び筋緊張低下によって引き起こされる病気で苦しむ患者の治療方法
US20070292536A1 (en) Composition and method for treating patients with high neurotransmitter levels
JPH05508843A (ja) アルツハイマー病の処置のための組成物及びそれを調製するための方法
Frucht et al. Parkinsonism-hyperpyrexia syndrome in Parkinson’s disease
KR100692235B1 (ko) 안지오텐신 ⅱ 길항물질의 신규한 용도
CN116194098A (zh) 用于治疗阿尔茨海默氏病的n'-(2-氯-6-甲基苯甲酰基)-4-甲基-3-[2-(3-喹啉基)乙炔基]苯甲酰肼
EP1635804B1 (de) Verwendung von eisen zur behandlung von aufmerksamkeitsdefiziten mit hyperaktivität bei kindern
WO2018109935A1 (ja) Ｐｔｓｄ患者において悪夢を予防、改善、又は治療する薬剤
Huddleston et al. Parkinsonism-hyperpyrexia syndrome in Parkinson’s disease
Babu et al. Adverse Drug Reactions in Drug-Resistant Tuberculosis Management: A Clinical Approach
Tariot et al. Anticonvulsants to treat agitation in dementia